Taiwan Liposome Company, Ltd. - Product Pipeline Review - 2013 - New Study Released

From: Fast Market Research, Inc.
Published: Mon Jan 27 2014

Global Market Direct's pharmaceuticals report, "Taiwan Liposome Company, Ltd. - Product Pipeline Review - 2013" provides data on the Taiwan Liposome Company, Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Taiwan Liposome Company, Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Taiwan Liposome Company, Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.


* Taiwan Liposome Company, Ltd. - Brief Taiwan Liposome Company, Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Taiwan Liposome Company, Ltd. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Taiwan Liposome Company, Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Taiwan Liposome Company, Ltd.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- http://www.fastmr.com/prod/769401_taiwan_liposome_company_ltd_product_pipeline.aspx?afid=301

Reasons to Get this Report

* Evaluate Taiwan Liposome Company, Ltd.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Taiwan Liposome Company, Ltd. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Taiwan Liposome Company, Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Taiwan Liposome Company, Ltd..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Taiwan Liposome Company, Ltd. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Taiwan Liposome Company, Ltd.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- La Jolla Pharmaceutical Company - Product Pipeline Review - 2013
- Zambon Company S.p.A. - Product Pipeline Review - 2013
- Kowa Company, Ltd. - Product Pipeline Review - 2013
- Bristol-Myers Squibb Company - Product Pipeline Review - 2013
- Daiichi Sankyo Company, Limited - Product Pipeline Review - 2013

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »